Vladimir Hachinski
Vladimir Hachinski is a and researcher based at the Schulich School of Medicine and Dentistry at Western University. He is also a Senior Scientist at London's Robarts Research Institute. His research pertains in the greatest part to stroke and dementia, the interactions between them and their joint prevention. He and John W. Norris helped to establish the world's first successful stroke unit at Sunnybrook Hospital in Toronto, and, by extension, helped cement stroke units as the standard of care for stroke patients. He discovered that the control of the heart by the brain is asymmetric, the  fight/flight (sympathetic) response being controlled by the right hemisphere and the rest and digest (parasympathetic) response being controlled by the left hemisphere and damage to one key component (the insula) can lead to heart irregularities and sudden death. This discovery has added fundamental knowledge to how the brain controls the heart and blood pressure and lays the foundation for helping prevent sudden death. Hachinski has held many prominent positions in the global neurology community, including editor-in-chief of the journal "Stroke" the leading publication in the field and president of the World Federation of Neurology and founder of  World Brain Alliance. He is a Fellow of the Royal Society of Canada (FRSC) and the Canadian Academy of Health Sciences (FCAHS), a Member of the Orders of Canada and Ontario, and the recipient of several national and international awards and recognitions for his research and advocacy. Early life, education, and early career. Hachinski was born in Zhytomyr, Ukraine, the eldest of three children. He moved with his family to Caripito, Venezuela as a child. The family moved to Port Perry, Ontario, Canada thereafter. He graduated from Port Perry High School a year later at the top of his class  . Hachinski received his MD in 1966 from the University of Toronto, and completed his residency in internal medicine and neurology in Toronto and Montreal, followed by a neurophysiology fellowship in Toronto. He received his formal accreditation in neurology as a Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC) in 1972. From 1973-74, a research fellowship with the Ontario Department of Health brought him to a cerebrovascular laboratory at the National Hospital for Nervous Diseases in London, England, and then to the Department of Clinical Physiology at Bispebjerg Hospital in Copenhagen, Denmark. Following this, he returned  to Toronto to take a staff position in the Department of Neurosciences at Sunnybrook Medical Centre, where he and Dr. John W. Norris established the MacLachlan Stroke Unit, Canada's first acute stroke unit. Hachinski remained at Sunnybrook until 1980, when he moved to London, Ontario to act as a neurology consultant for its major health centres: University Hospital, Victoria Hospital, St. Joseph's Hospital, and the London Psychiatric Hospital. He was hired concurrently as a professor at Western University (then called the University of Western Ontario). During this time (and until 1990), he also acted as Director of the  Investigative Stroke Unit at London's University Hospital. In 1987, he earned a Master of Science degree from McMaster University in Hamilton, Ontario, studying in the Department of Epidemiology and Biostatistics with a focus on design, measurement, and evaluation. The University of London’s highest earned degree, Doctor of Science (in Hachinski's case, in medicine), was conferred upon him in 1988 for his “contributions to migraine, stroke, and dementia.” Research. Vascular cognitive impairment. At the beginning of Hachinski's career, the prevailing view was that most dementias were caused by hardened brain arteries (mental deterioration via cerebral atherosclerosis). Hachinski  showed in 1975 that, in fact, only a small minority of dementias were so-caused, and that most were “multi-infarct dementias” — dementias caused by multiple, small, often imperceptible strokes. The terms “vascular dementia” and “vascular cognitive impairment” would later be widely adopted to describe all cognitive impairments "with a vascular component" in order to distinguish them from primary degenerative dementia (i.e., Alzheimer disease and senile dementia) and to emphasize that they are preventable and treatable, insofar as their vascular causes (i.e., atherosclerosis, stroke, etc.) are treatable as well. He has offered an explanation for the origin of some of  these lesions and associated symptoms through his concept of ambibaric brain.  He postulates that the brain has two complementary blood pressure systems, one high and one low and disturbances in each lead to different types of lesions. At the time, the prevalent view that dementia ensued from the slow strangulation of the brain's blood supply by hardening of the arteries spawned a whole industry of brain vessel “vasodilators”. He showed that brain blood vessels in dementia were not “hardened” and that “vasodilators” were not only expensive but useless. He also developed an eponymic “ischemic score” that continues to be  widely used to identify the vascular (treatable and preventable) component of dementia. Successfully distinguishing between the two is tremendously important for patient prognosis, as treating the vascular causes of dementias can mitigate their effects. The scale is a prolifically cited tool, and has since been validated and optimized for use outside of clinical research settings. In 1986, the journal, Archives of Neurology published a series of papers by Hachinski, Harold Merskey and colleagues on the rarefaction of white matter in the brains of elderly people. These papers were among the first to recognize the importance of white matter lesions as  risks for stroke and dementia. Rarefaction of white matter in the brain had already been shown to be correlated with a wide variety of health problems, but these papers were groundbreaking for two reasons especially: First, they introduced the term, “leukoaraiosis,” a word derived by Hachinski, Paul Potter and Harold Merskey to etymologically and Hippocratically describe the rarefaction; and second, they specifically highlighted a previously underappreciated relationship between vascular risk factors for cognitive impairment (i.e., treatable and preventable risk factors for both stroke and multi-infarct dementia) and leukoaraiosis. By coining “leukoaraiosis,” Hachinski drew medical practitioners’ attention to these white  matter hypodensities in the brains of patients affected by small strokes. Hachinski continued to develop and promote his novel approach to dementia — viewing it as a product of preventable and treatable vascular problems, thus itself also amenable to prevention, delay, and mitigation — eventually coining it as the “vascular cognitive impairment approach” to dementias in 1994. This proactive and preventative, rather than solely retroactive and treatment-based approach included other novel coinages, such as “brain at risk,” describing patients without cognitive impairment but with risk factors for it. Even with these developments, available diagnostic criteria for dementias continued to present a  challenge, as they were not able to capture the complex, interactive, and adaptive nature of brain pathologies leading to dementia. For this reason, in 2006, Hachinski decided to lead (with Gabrielle LeBlanc) the development of minimal common standards to describe the clinical, neuropsychological, imaging, genetic, and neuropathological features of cognitive impairment. This standardization has allowed for ongoing improvement of the diagnostic criteria with new knowledge, comparison of results from different studies, and analysis & meta-analysis using “big data” techniques. Acute stroke. The MacLachlan Stroke Unit at Sunnybrook, Canada's first stroke unit (est. 1975), was almost 20 years ahead of  its time; stroke units have been considered the most effective treatment for stroke patients of all ages, severities, and types only since the 1990s. Hachinski and Norris' early work with that unit and others helped to cement the importance of dedicated wards for stroke patient monitoring and treatment, but his research over the next 17 years also shaped how those treatments and monitoring methods are executed. In 1986, while he was Director of the Investigative Stroke Unit at University Hospital in London, he developed (with Robert Coté), the Canadian Neurological Scale – a simple but systematic tool, usable by non-physicians  for evaluating and monitoring the neurological status of patients with acute stroke. Later, in 1992, he (with collaborators David Cechetto and Stephen Oppenheimer) began work to explore possible mechanisms for observed increases in catecholamines, cardiac enzymes, arrhythmias, and sudden death following acute stroke. This would eventually lead to the discovery that the insula of the brain is the mediator of these various cardiac complications. Knowing this alters doctors to monitor the heart closely, to prevent sudden death. The scientific bases for preventing stroke and dementia together have been summarized by an international panel of experts. (Refs:  Hachinski V, Einhäupl K , Ganten D, Alladi S, Brayne C, Stephan BCM, Sweeney MD, Zlokovic B, Iturria-Medina Y, Iadecola C, Nishimura N, Schaffer CB, Whitehead SN, Black SE, Østergaard L, Wardlaw J, Greenberg S, Friberg L, Norrving B, Rowe B, Joanette Y, Hacke W, Kuller L, Dichgans M, Endres M, Khachaturian ZS. Preventing dementia by preventing stroke: The Berlin Manifesto. Alz & Dement. 2019;15:962-984) (Hachinski V, Ganten D, Lackland D, Kreutz R, Tsioufis K, Hacke W on behalf of the World Stroke Organization, the World Heart Federation, the World Hypertension League and the European Society of Hypertension.  Implementing the proclamation of stroke and  potentially preventable dementias.  Int J of Stroke. 2018;13:780-786 Since stroke, heart disease and dementia represent risks for each other and share the same risk and protective factors, he advocates preventing this “Triple Threat” together (Ref: Brain health: Curbing stroke, heart disease and dementia.  Neurology 2021 (in press)) He leads a multidisciplinary team studying for the first time together environmental, socioeconomic and individual risk and protective factors in the joint prevention of stroke, heart disease and dementia. He is a participant in an initiative to make brain health the top priority.  He has offered a definition of brain health based  on the World Health Organization definition of health” “A state of complete physical, mental and social well-being through a full, balanced, continuous development and exercise of the brain (Hachinki V, Avan A, Gilliland J, Oveisgharan S.  A new definition of brain health.  Lancet Neurol. 2021 (in press) Stroke prevention. In addition to his interest in the mechanisms of stroke and best practices for treatment, Hachinski also has a keen research interest in stroke prevention. He acted as the principal neurological investigator on several seminal, multicentre studies, beginning with the Canadian-American Ticlopidine study (1983–88) and the Extracranial/Intracranial Arterial  Bypass Surgery trial (1983–87). The former showed a preventative advantage to the drug Ticlopidine over commonly-prescribed Aspirin, while the latter showed that the increasingly popular and very expensive EC/IC arterial bypass procedure did not significantly reduce the risk of ischemic stroke. In 2003, alongside several other researchers, Hachinski began a proof of principle study through the Canadian Stroke Network on secondary stroke prevention. The study aimed to explore the efficacy of stroke risk-factor counselling and monitoring in effecting lifestyle changes and prescription adherence in patients, as well as exploring barriers and testing possible solutions to effective stroke  risk-factor management. The preliminary results were extremely promising, showing that the addition of a lay-person to usual stroke care results in far better outcomes and reduced risk-factors. That initial study led to the creation of a multi-centre study in 2009 under the direction of Richard Chan. Population health. Hachinski's home province of Ontario, Canada introduced a formal Provincial Stroke System in 2000. At the time, Hachinski hypothesized that this increased attention to stroke care would result not only in decreased incidence of stroke, but also in some dementias, since they share most of the same  treatable risk factors. The prediction was correct, and he is therefore advocating a strategy of preventing some dementias through the prevention of stroke. With Luciano Sposato, Moira Kapral and others, he showed, for the first time, a concomitant decrease in the incidence of stroke and dementia at a whole-population level. Key administrative positions and advocacy. Hachinski has held numerous high-level administrative positions in the medical community during his career. Non-scientific publications. Popular (medicine). Hachinski's primary popular medicine contributions have been publications in cooperation with his son, Vladimir, and daughter, Larissa. With Vladimir, he published an article  in the Journal of the Canadian Medical Association called, "Music and the Brain" in August 1994. With Larissa, he published the book, "Stroke: A Comprehensive Guide to Brain Attack" in 2003. Coining and employing the term “brain attack,” the book was written to increase public awareness of the importance of adequate stroke care and early intervention. Medical historical. An interest in the history of medicine has led Hachinski to publish several articles on the subject over the course of his career: Arts and humanities. In addition to his medical research, Hachinski is also respectably accomplished in poetry, music, and history  (including history of medicine). He possesses an honours degree in history from the University of London, UK, is a Corresponding Member of the North American Academy of the Spanish Language (a corresponding academy of the Royal Spanish Academy) and has published a poetry anthology, "Resonancias", in Spanish under the pen name Alejandro Aranda. In addition, "Dream Waltz," composed by Hachinski and orchestrated by Jason Stanford (Professor of Theory and Composition at Western University), premiered at the Musikverein in Vienna, Austria by the Brno Philharmoniker on September 24, 2013. Finally, he is fond of coining slogans and aphorisms: Honours and recognition . Awards/recognitions. Over the course of his career, Hachinski has been the recipient of many awards and recognitions in his field. The most notable and significant are outlined below. Honorary degrees. Hachinski holds four honorary doctorates. The first, Doctor of Medicine honoris causa from the University of Salamanca, Spain, was awarded in 2000. This was followed by Doctor of the University honoris causa from the University of Buenos Aires, Argentina (2005), Doctor of Medicine honoris causa from the University of Cordoba, Argentina (2007), and Doctor honoris causa from the Russian Academy of Medical Sciences (2012).